Article

Transaminase concentrations cannot separate NAFL and NASH in morbidly obese patients independent of histological algorithm

2020-12-21

Abstract excerpt

<h4>Background: </h4> Prevalence of non-alcoholic fatty liver disease (NAFLD) in the German population is 20–30%. Liver biopsy to detect non-alcoholic steatohepatitis (NASH) let alone for NAFLD monitoring is not feasible. Current practice regards elevated serum concentrations of liver enzymes as indicator for NAFLD or NASH. In this study we analyzed if an adjustment of the upper limit of normal (ULN) for serum l...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3dfdcd69-ca75-5b3a-a2c4-29578c7e5ae1
DOI: 10.21203/rs.3.rs-129749/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Transaminase concentrations cannot separate NAFL and NASH in morbidly obese patients independent of histological algorithmDOI 10.21203/rs.3.rs-129749/v1Read

Nonalcoholic fatty liver disease test: an external validation cohort.Semantic proximity Read

Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods.Semantic proximity Read

Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee.Semantic proximity Read

Obesity-associated nonalcoholic fatty liver disease.Semantic proximity Read

Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.Semantic proximity Read

The Nimble Stage 1 Study Validates Diagnostic Circulating Biomarkers for Nonalcoholic SteatohepatitisSemantic proximity Read

MASLD versus MAFLD in lean steatotic liver disease: diagnostic overlap, inclusivity, and the metabolically healthy lean phenotype.Semantic proximity Read

Discordance Between FIB-4 and BAST Fibrosis Risk Classifications in Obese Patients With MASLD: Results From the OBREDI-TR StudySemantic proximity Read

How Effective Are Serum Scoring Systems in Predicting Liver Fibrosis Caused by Chronic Hepatitis B? Serum Scoring Systems and Liver FibrosisSemantic proximity Read

Nonalcoholic fatty liver disease: what the pathologist can tell the clinician.Semantic proximity Read

Using the FIB-4, automatically calculated, followed by the ELF test in second line to screen primary care patients for liver diseaseSemantic proximity Read

Association between positivity of serum autoantibodies and liver disease severity in patients with biopsy-proven NAFLD.Semantic proximity Read